Effectively Screening for Coronary Artery Disease in Patients Undergoing Orthotopic Liver Transplant Evaluation

Coronary artery disease (CAD) is prevalent in patients with end-stage liver disease and associated with poor outcomes when undergoing orthotopic liver transplantation (OLT); however, noninvasive screening for CAD in this population is less sensitive. In an attempt to identify redundancy, we reviewed...

Full description

Saved in:
Bibliographic Details
Main Authors: Bryan C. Lee, Feng Li, Adam J. Hanje, Khalid Mumtaz, Konstantinos D. Boudoulas, Scott M. Lilly
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2016/7187206
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559364144103424
author Bryan C. Lee
Feng Li
Adam J. Hanje
Khalid Mumtaz
Konstantinos D. Boudoulas
Scott M. Lilly
author_facet Bryan C. Lee
Feng Li
Adam J. Hanje
Khalid Mumtaz
Konstantinos D. Boudoulas
Scott M. Lilly
author_sort Bryan C. Lee
collection DOAJ
description Coronary artery disease (CAD) is prevalent in patients with end-stage liver disease and associated with poor outcomes when undergoing orthotopic liver transplantation (OLT); however, noninvasive screening for CAD in this population is less sensitive. In an attempt to identify redundancy, we reviewed our experience among patients undergoing CAD screening as part of their OLT evaluation between May 2009 and February 2014. Demographic, clinical, and procedural characteristics were analyzed. Of the total number of screened patients (n=132), initial screening was more common via stress testing (n=100; 75.8%) than coronary angiography (n=32; 24.2%). Most with initial stress testing underwent angiography (n=52; 39.4%). Among those undergoing angiography, CAD was common (n=31; 23.5%). Across the entire cohort the number of traditional risk factors was linearly associated with CAD, and those with two or more risk factors were found to have CAD by angiography 50% of the time (OR 1.92; CI 1.07–3.44, p=0.026). Our data supports that CAD is prevalent among pre-OLT patients, especially among those with 2 or more risk factors. Moreover, we identified a lack of uniformity in practice and the need for evidence-based and standardized screening protocols.
format Article
id doaj-art-970603fcfb6644f0b3aad5282ba7d7fa
institution Kabale University
issn 2090-0007
2090-0015
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Transplantation
spelling doaj-art-970603fcfb6644f0b3aad5282ba7d7fa2025-02-03T01:30:14ZengWileyJournal of Transplantation2090-00072090-00152016-01-01201610.1155/2016/71872067187206Effectively Screening for Coronary Artery Disease in Patients Undergoing Orthotopic Liver Transplant EvaluationBryan C. Lee0Feng Li1Adam J. Hanje2Khalid Mumtaz3Konstantinos D. Boudoulas4Scott M. Lilly5Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USADepartment of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USADivision of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USADivision of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USADivision of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USADivision of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USACoronary artery disease (CAD) is prevalent in patients with end-stage liver disease and associated with poor outcomes when undergoing orthotopic liver transplantation (OLT); however, noninvasive screening for CAD in this population is less sensitive. In an attempt to identify redundancy, we reviewed our experience among patients undergoing CAD screening as part of their OLT evaluation between May 2009 and February 2014. Demographic, clinical, and procedural characteristics were analyzed. Of the total number of screened patients (n=132), initial screening was more common via stress testing (n=100; 75.8%) than coronary angiography (n=32; 24.2%). Most with initial stress testing underwent angiography (n=52; 39.4%). Among those undergoing angiography, CAD was common (n=31; 23.5%). Across the entire cohort the number of traditional risk factors was linearly associated with CAD, and those with two or more risk factors were found to have CAD by angiography 50% of the time (OR 1.92; CI 1.07–3.44, p=0.026). Our data supports that CAD is prevalent among pre-OLT patients, especially among those with 2 or more risk factors. Moreover, we identified a lack of uniformity in practice and the need for evidence-based and standardized screening protocols.http://dx.doi.org/10.1155/2016/7187206
spellingShingle Bryan C. Lee
Feng Li
Adam J. Hanje
Khalid Mumtaz
Konstantinos D. Boudoulas
Scott M. Lilly
Effectively Screening for Coronary Artery Disease in Patients Undergoing Orthotopic Liver Transplant Evaluation
Journal of Transplantation
title Effectively Screening for Coronary Artery Disease in Patients Undergoing Orthotopic Liver Transplant Evaluation
title_full Effectively Screening for Coronary Artery Disease in Patients Undergoing Orthotopic Liver Transplant Evaluation
title_fullStr Effectively Screening for Coronary Artery Disease in Patients Undergoing Orthotopic Liver Transplant Evaluation
title_full_unstemmed Effectively Screening for Coronary Artery Disease in Patients Undergoing Orthotopic Liver Transplant Evaluation
title_short Effectively Screening for Coronary Artery Disease in Patients Undergoing Orthotopic Liver Transplant Evaluation
title_sort effectively screening for coronary artery disease in patients undergoing orthotopic liver transplant evaluation
url http://dx.doi.org/10.1155/2016/7187206
work_keys_str_mv AT bryanclee effectivelyscreeningforcoronaryarterydiseaseinpatientsundergoingorthotopiclivertransplantevaluation
AT fengli effectivelyscreeningforcoronaryarterydiseaseinpatientsundergoingorthotopiclivertransplantevaluation
AT adamjhanje effectivelyscreeningforcoronaryarterydiseaseinpatientsundergoingorthotopiclivertransplantevaluation
AT khalidmumtaz effectivelyscreeningforcoronaryarterydiseaseinpatientsundergoingorthotopiclivertransplantevaluation
AT konstantinosdboudoulas effectivelyscreeningforcoronaryarterydiseaseinpatientsundergoingorthotopiclivertransplantevaluation
AT scottmlilly effectivelyscreeningforcoronaryarterydiseaseinpatientsundergoingorthotopiclivertransplantevaluation